Business Wire

JEONJU-CITY

Share
Jeonju Bibimbap Festival 2022 to be Held as Genuine Cultural Food Festival

Jeonju, a city of gastronomy, will host Jeonju Bibimbap Festival 2022, a representative cultural food festival of Korea, from October 6 to 10 in the vicinity of Jeonju Hyanggyo in Jeonju Hanok Village. Under the theme of Bibimbap, the event will offer a wide range of local dishes along with cultural performances.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005035/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Jeonju Bibimbap Festival 2022 opens as a genuine cultural food festival from October 6 to 10 in the vicinity of Jeonju Hyanggyo in Jeonju Hanok Village under the theme of Bibimbap with various local dishes along with cultural performances. (Graphic: Business Wire)

The opening ceremony, 'Gaematshik,' which means “opening the taste of Jeonju,” will be started with pre-events including 'Hyanggyo-gil B-boy Contest' and 'Bibap Race.' It will be followed by 'Bibap Art Wall,' a display of an art wall created using Bibimbap ingredients, 'Bibapcon,' a congratulatory performance by a fusion Korean traditional music group, 'Bibim Gimbap Contest,' a new-concept contest proposed by the festival, and 'Bibap Archiving Exhibition.'

The key programs of the festival are 'Bibap Picnic,' a picnic at Jeonju Hyanggyo, 'Bibap Party' to enjoy finger food and drinks with music mixed by a DJ, 'Bimaek Party,' a party to enjoy dishes with beer, 'Bibap Theater' to watch movies using wireless headsets, and 'Bibap Table,' a row of food stalls on Dongmun-gil.

The event will also offer around 20 standing programs to please the eyes, ears, and tastebuds of Jeonju citizens and tourists.

Jeonju’s tastes can be enjoyed at 'Stories of Jeonju Food Masters,' an opportunity to meet with Jeonju’s food experts, reputed families, and next-generation masters, 'Insaeng Matchan' to prepare dishes only for a single couple, 'Bibap Restaurant' serving Bibim dishes developed for Jeonju Bibimbap Festival, 'Bibap Jumak,' a tavern with Generation MZ chefs prepared dishes, 'Bibap Food Court,' a street food zone serving a variety of menus, and 'Parasol Tables' installed along a street by the stream.

A range of entertainment programs including a crafts flea market, a parade performance, an exhibition of tableware created by master craftsmen, and experience, game, and event zones for tourists will also be available.

“We will develop this event into a safe and healthy local festival model by operating programs based on cooperation with local residents and small businesses to comply with the COVID-19 quarantine regulations,” said a Jeonju City official. “We invite everyone to the festival to enjoy Jeonju’s food and culture.”

The key programs of Jeonju Bibimbap Festival 2022 will be held on a reservation basis. For details, contact Jeonju Bibimbap Festival Secretariat (Tel.: +82-63-283-1141).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220927005035/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 07:00:00 CET | Press release

MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current launches, and support further product alliances and acquisitions. In just 3 years, Avanzanite has entered 3 strategic alliances and actively launched 3 rare disease medicines. Avanzanite’s Q3 2025 revenue tripled year-on-year and climbed over 20% quarter-on-quarter. Avanzanite is a unique, fully integrated partner for biotech and pharma innovators seeking to market and distribute their rare disease medicines in Europe. A new pan-European standard is being set for orphan medicine launches and patient access, with no one left behind. Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release

Over 30 Million Users Benefit From Ant International’s Bettr Credit Tech Solutions18.11.2025 04:35:00 CET | Press release

Powering the Next Wave of MSME Growth with Digital Platforms in Emerging MarketsThere was a threefold year-on-year increase in eligible customers reached through partners using Bettr's credit tech solutions by the end of October 2025.The solution features an AI-driven, alternative-data-powered credit engine that can help partner platforms to cut credit policy deployment from weeks to minutes.Partnership with Dock, a leading Brazilian payments and banking technology provider, will expand the deployment of Bettr’s credit tech solutions. Bettr, a leading provider of inclusive financial services and technology business under Ant International, today announced the launch of its proprietary tailored, one-stop credit tech solutions designed to help digital platforms build and scale their lending businesses to better serve micro, small and medium enterprises (MSMEs) in emerging markets. Bettr's credit tech solutions supported over 30 million customers to gain access to credit services through

Ant International Deepens Participation in Project Ensemble as New Architecture Community Member18.11.2025 04:00:00 CET | Press release

Ant International has been a participant in the Ensemble Sandbox since 2024 Ant International today announced it has joined Project Ensemble’s Architecture Community to support the design and advancement of Hong Kong’s tokenisation ecosystem. As a Community member, it will be more involved in defining industry standards and supporting the development of Hong Kong’s tokenisation market, together with the Hong Kong Monetary Authority (HKMA) and leading peers. A fintech representative on the Community, Ant International will also contribute its technological and innovation capabilities in tokenisation to support broader industry adoption. This comes at a time when Project Ensemble reaches a new milestone with EnsembleTX, which will see it move from sandbox experiments to live market use within a pilot environment. Through EnsembleTX, Ant International will continue to broaden its partnerships with banks and other committee members, contributing to real-world use cases of tokenisation in r

Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg18.11.2025 03:51:00 CET | Press release

Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in EuropeOmlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled syringe (PFS).The European Commission (EC) approved Omlyclo™ 75 mg/0.5ml and 150mg/1ml solution for injection in pre-filled syringe in May 2024. Omlyclo™ is indicated for the treatment of patients with allergic asthma, chronic spontaneous urticaria (CSU) and chronic rhinosinusitis with nasal polyps (CRSwNP). “The additional strength of Omlyclo™ 300mg can significantly decrease the frequency of injections, and reduce injection burden and discomfort, without compromising efficacy and safety,” said Nam Lee, Vice President of Global Medical Affairs at Celltrion. “These

2026 Mitsui Chemicals Catalysis Science Awards18.11.2025 03:00:00 CET | Press release

Online applications are open until December 25, 2025 Mitsui Chemicals, Inc. has announced that online applications for the 2026 Mitsui Chemicals Catalysis Science Award have been open since September 1, 2025. The application period will run from September 1 to December 25, 2025. Aiming to contribute to the sustainable development of chemistry and the chemical industry, Mitsui Chemicals established the Mitsui Chemicals Catalysis Science Awards in 2004. The awards consist of the Catalysis Science Award and the Catalysis Science Award for Creative Work, which recognize outstanding achievements in the field of catalysis science. To date, the awards have been conferred on 33 researchers within Japan and overseas. Past recipients include individuals who have gone on to be highly acclaimed worldwide, receiving honors such as the Nobel Prize in Chemistry and other prestigious Japanese and international awards. We welcome applications from a wide range of R&D fields, including solid catalysts,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye